Cognitive Trajectories After Surgery, a Clinical, Observational Feasibility Study
NCT ID: NCT05564195
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2023-01-10
2024-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Older People's Neurocognitive Recovery After Cardiac Surgery
NCT06469515
Patients Experiences of Early Postoperative Cognition
NCT05361460
Implementation of a Cognitive Training Program to Reduce the Risk of Postoperative Cognitive Dysfunction
NCT03620968
Clinical Outcomes in Elderly Patients With Preoperative Cognitive Dysfunction
NCT03143595
Study of Depressive Symptoms Predicting Postoperative Cognitive Dysfunction
NCT02210312
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I) Test recruitment process and measure attrition rate. II) To establish whether it is possible to detect early signs of neurocognitive decline, using a digital postoperative cognitive screening tool i.e. Mindmore-P.
III) To investigate if there are any associations between choice of anesthetic drugs, delirium, duration of anesthesia, preoperative frailty, depression symptoms, postoperative delirium, physical function, and early postoperative recovery.
IV) Determine the usability and feasibility of Mindmore-P. V) Determine patients' experiences of early cognitive recovery in relation to signs of cognitive decline or no signs measured bythe four tests included in Mindmore-P
METHODS AND ANALYSIS Study design This is an observational feasibility study.
Participants included will be patients undergoing planned non-cardiac surgery with general anesthesia (n=50) at a hospital in Stockholm, Sweden. The sample size is based on the incidence of early cognitive decline at 1-2 weeks postoperatively of approximately 13-25%.
Inclusion criteria:
1. \>60 years of age undergoing elective non-cardiac surgery with general anesthesia.
2. Duration of surgery \>60 minutes
3. Mini-mental state examination (MMSE) score \>24.
Exclusion criteria:
1. Unable to read and speak Swedish
2. Uncorrected severe visual or auditory disorder, disease of the central nervous system, psychiatric diseases including alcoholism or drug dependence, current motor impairment in dominant hand, or colour-blindness.
Recruitment At the patient's preoperative anaesthesia consultation, a research nurse will provide oral and written information about the study. The details of the study and its potential benefits as well as risks will be explained carefully to the patient. If the patient agrees to participate in the study, they will undergo a MMSE screening to examine if they are eligible for the study.
Outcomes, look below.
Analysis Descriptive statistics of demographic data will be presented with number, percentage, and mean (sd) or min-max, as appropriate. As recommended by Borchers et al review from 2021, mild POCD (1-2 standard deviation \[sd\]) and major POCD (\>2 sd) will be specified for each test result and POCD is present if at least two tests indicates decline.
Usability and attrition rates will be presented with descriptive statistics. Preoperative depression (GDS), frailty (CFS), postoperative recovery (SwQoR), functional status (WHODAS) will be compared between the groups, using Kruskal Wallis ANOVA followed by Mann-Whitney U-test and a Bonferroni correction. To analyse intraindividual differences over time in cognitive performance, the same statistical tests will be used as well as multivariate logistic regression analysis. A p-value of \<0.05 will be statistically significant in all analyses, Qualitative data will be analysed with thematic analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing elective surgery with a duration of > 60 minutes
Participants included will be patients undergoing planned non-cardiac surgery with general anesthesia that are \>60 years of age, have a Mini-mental state examination score of \>24, are able to speak Swedish and does not suffer from uncorrected severe visual or auditory disorder, disease of the central nervous system, psychiatric diseases including alcoholism or drug dependence, current motor impairment in dominant hand, or colour-blindness.
Postoperative cognitive function
Digital cognitive tests - Mindmore-P, will be used to assess neurocognitive capacity and includes tests of verbal episodic memory, executive functions, visuospatial function and attention. The cognitive tests are self-administered on a touch screen tablet (10.1" 20-30 min Windows). The Mindmore-P is a web-application running on a full-screen Chrome browser. The test is administered by using a capacitive touchscreen with features that record detailed information such as timing, pauses, and lifting of finger from the touchscreen. Speech recognition is used in the screening of verbal memory and language.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Postoperative cognitive function
Digital cognitive tests - Mindmore-P, will be used to assess neurocognitive capacity and includes tests of verbal episodic memory, executive functions, visuospatial function and attention. The cognitive tests are self-administered on a touch screen tablet (10.1" 20-30 min Windows). The Mindmore-P is a web-application running on a full-screen Chrome browser. The test is administered by using a capacitive touchscreen with features that record detailed information such as timing, pauses, and lifting of finger from the touchscreen. Speech recognition is used in the screening of verbal memory and language.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Duration of surgery \>60 minutes
* Mini-mental state examination score \>24.
Exclusion Criteria
* Unable to read and speak Swedish
* Uncorrected severe visual or auditory disorder,
* Disease of the central nervous system
* Psychiatric diseases
* Alcoholism or drug dependence
* Current motor impairment in dominant hand
* Colour-blindness.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ersta Hospital, Sweden
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ulrica Nilsson
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulrica Nilsson, Professor
Role: PRINCIPAL_INVESTIGATOR
Karolinska Insitutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ulrica Nilsson
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Amirpour A, Eckerblad J, Thorell A, Bergman L, Nilsson U. Usability and feasibility of a digital cognitive screening tool measuring older adults' early postoperative neurocognitive recovery: a protocol for a pilot study. BMJ Open. 2023 Jul 21;13(7):e070404. doi: 10.1136/bmjopen-2022-070404.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-03593-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.